10-Q 1 d559923d10q.htm 10-Q 10-Q
Table of Contents
0001852889--12-31falseQ300-0000000Cricket Square Elgin AvenueOn March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations. 0001852889 2022-12-31 0001852889 2023-09-30 0001852889 2022-07-01 2022-09-30 0001852889 2023-07-01 2023-09-30 0001852889 2023-01-01 2023-09-30 0001852889 2022-01-01 2022-09-30 0001852889 2022-01-01 2022-12-31 0001852889 2022-04-01 2022-06-30 0001852889 2023-01-01 2023-03-31 0001852889 2023-04-01 2023-06-30 0001852889 2022-03-01 2022-03-31 0001852889 2022-01-01 2022-03-31 0001852889 2022-08-31 2022-08-31 0001852889 2023-08-11 0001852889 2023-08-11 2023-08-11 0001852889 2021-12-31 0001852889 2022-09-30 0001852889 2022-03-31 0001852889 2023-06-30 0001852889 2022-06-30 0001852889 2023-03-31 0001852889 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001852889 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001852889 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001852889 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-07-01 2022-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001852889 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 us-gaap:IPOMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember ivca:PublicWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-01-01 2023-09-30 0001852889 ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 srt:MaximumMember ivca:ProposedOfferingMember 2023-01-01 2023-09-30 0001852889 ivca:ProposedOfferingMember ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 ivca:SponsorMember ivca:WorkingCapitalLoansMember 2023-01-01 2023-09-30 0001852889 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001852889 ivca:ClassaOrdinaryShareAndRedeemableWarrantMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001852889 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-07-01 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001852889 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001852889 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852889 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2022-05-12 2022-05-12 0001852889 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-05-12 2022-05-12 0001852889 ivca:SponsorMember ivca:PrivatePlacementWarrantsMember 2022-05-12 2022-05-12 0001852889 us-gaap:OverAllotmentOptionMember ivca:SponsorMember ivca:PrivatePlacementWarrantsMember 2022-05-12 2022-05-12 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2021-03-12 2021-03-12 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-01 2022-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2022-03-01 2022-03-31 0001852889 ivca:AgreementToContributeToTheTrustAccountMember ivca:SponsorMember 2023-08-11 2023-08-11 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-22 2022-03-22 0001852889 us-gaap:SubsequentEventMember 2023-10-11 2023-10-11 0001852889 us-gaap:SubsequentEventMember 2023-11-13 2023-11-13 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001852889 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-04-01 2023-06-30 0001852889 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001852889 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001852889 us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:USTreasurySecuritiesMember 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001852889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member ivca:PublicWarrantsMember 2023-09-30 0001852889 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001852889 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001852889 us-gaap:IPOMember us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-09-30 0001852889 ivca:ProposedOfferingMember 2023-09-30 0001852889 us-gaap:CommonClassAMember ivca:PublicWarrantsMember 2023-09-30 0001852889 us-gaap:IPOMember 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember 2023-09-30 0001852889 srt:MaximumMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember ivca:PublicWarrantsMember 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-09-30 0001852889 srt:MaximumMember us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2023-09-30 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-09-30 0001852889 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001852889 ivca:SponsorMember 2023-09-30 0001852889 ivca:SponsorMember ivca:WorkingCapitalLoansMember 2023-09-30 0001852889 ivca:ExtensionLoansMember 2023-09-30 0001852889 ivca:AdministrativeServicesAgreementMember 2023-09-30 0001852889 us-gaap:CommonClassAMember 2022-12-31 0001852889 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001852889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-12-31 0001852889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member ivca:PublicWarrantsMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001852889 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852889 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 us-gaap:OverAllotmentOptionMember 2022-12-31 0001852889 us-gaap:CommonClassBMember 2022-12-31 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-12-31 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001852889 ivca:SponsorMember 2022-12-31 0001852889 ivca:ExtensionLoansMember 2022-12-31 0001852889 ivca:AdministrativeServicesAgreementMember 2022-12-31 0001852889 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-05-12 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-31 0001852889 us-gaap:CommonClassBMember srt:MaximumMember us-gaap:OverAllotmentOptionMember 2022-03-31 0001852889 ivca:UnsecuredPromissoryNoteMember ivca:SponsorMember 2021-03-12 0001852889 ivca:AgreementToContributeToTheTrustAccountMember ivca:SponsorMember 2023-08-11 0001852889 us-gaap:CommonClassAMember 2023-08-11 0001852889 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember srt:MaximumMember 2022-03-22 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-22 0001852889 us-gaap:CommonClassAMember 2023-11-30 0001852889 us-gaap:CommonClassBMember 2023-11-30 0001852889 ivca:SponsorMember 2023-08-09 0001852889 us-gaap:SubsequentEventMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember 2023-10-10 0001852889 ivca:SponsorMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember us-gaap:SubsequentEventMember 2023-11-09 0001852889 us-gaap:SubsequentEventMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember 2023-10-10 2023-10-10 0001852889 ivca:SponsorMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember us-gaap:SubsequentEventMember 2023-11-09 2023-11-09 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-01-01 2022-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-09-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-12-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001852889 us-gaap:RetainedEarningsMember 2023-03-31 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852889 us-gaap:RetainedEarningsMember 2021-12-31 0001852889 us-gaap:RetainedEarningsMember 2022-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001852889 us-gaap:RetainedEarningsMember 2022-06-30 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-06-30 0001852889 us-gaap:RetainedEarningsMember 2023-06-30 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2021-12-31 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-06-30 iso4217:USD xbrli:shares utr:Day utr:Year xbrli:pure iso4217:USD xbrli:shares utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
 
10-Q
 
 
(Mark One)
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30,
2023
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
 
                    
 
to
 
                    
Commission File Number
 
001-41383
 
 
INVESTCORP INDIA ACQUISITION CORP
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
 
N/A
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification No.)
Century Yard, Cricket Square
Elgin Avenue
PO Box 1111
George Town
Grand Cayman, Cayman Islands
 
KY1-1102
(Address of principal executive offices and zip code)
(302)
 
738-7210
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading
Symbols
 
Name of Each Exchange
on Which Registered
Units, each consisting of one Class A ordinary share and
one-half
of one redeemable warrant
 
IVCAU
 
The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share
 
IVCA
 
The Nasdaq Stock Market LLC
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
 
IVCAW
 
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
 
S-T
 
(Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
 
non-accelerated
 
filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
 
12b-2
 
of the Exchange Act:
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated
filer
     Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule
 
12b-2
 
of the Exchange Act).    Yes      No  ☐
As of November 30
, 2023, there were 9,789,446 Class A ordinary shares, par value $0.0001, and 6,468,750 of the registrant’s Class B ordinary shares, par value $0.0001 per share, issued and outstanding.
 
 
 


Table of Contents

INVESTCORP INDIA ACQUISITION CORP

TABLE OF CONTENTS

 

          Page  
PART I. FINANCIAL INFORMATION   
Item 1.    Financial Statements      1  
     Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022    1  
     Condensed Statements of Operations for the three and nine months ended September 30, 2023 (Unaudited) and
September 30, 2022 (Unaudited)
   2  
     Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2023
(Unaudited) and September 30, 2022 (Unaudited)
   3  
     Condensed Statements of Cash Flows for the nine months ended September 30, 2023 (Unaudited) and
September 30, 2022 (Unaudited)
   4  
     Notes to Condensed Financial Statements (Unaudited)    5  
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations      19  
Item 3.    Quantitative and Qualitative Disclosures About Market Risk      24  
Item 4.    Controls and Procedures      24  
PART II. OTHER INFORMATION   
Item 1.    Legal Proceedings      25  
Item 1A.    Risk Factors      25  
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities      25  
Item 3.    Defaults Upon Senior Securities      25  
Item 4.    Mine Safety Disclosures      26  
Item 5.    Other Information      26  
Item 6.    Exhibits      27  


Table of Contents
http://fasb.org/us-gaap/2023#RelatedPartyMemberhttp://fasb.org/us-gaap/2023#RelatedPartyMemberP3DP3Dhttp://www.ivcau.com/20230930#FormationsCostsAndOperatingExpenses
PART I—FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS.
INVESTCORP INDIA ACQUISITION CORP
CONDENSED BALANCE SHEETS
 
    
September 30,
2023

(Unaudited)
   
December 31,
2022
 
ASSETS
                
Current Assets
                
Cash
   $ 30,414     $ 635,565  
Other assets – current
     317,822       509,987  
    
 
 
   
 
 
 
Total current assets
     348,236       1,145,552  
Other assets –
non-current
              183,345  
Investments held in Trust Account
     106,318,563       270,278,722  
    
 
 
   
 
 
 
Total Assets
  
$
106,666,799
 
 
$
271,607,619
 
    
 
 
   
 
 
 
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT
                
Current Liabilities
                
Accrued expenses
   $ 536,304     $ 206,748  
Promissory note – related party
     200,000       —    
Due to Sponsor
     39,435       42,424  
    
 
 
   
 
 
 
Total current liabilities
     775,739       249,172  
Warrant liability
     2,031,751       1,479,713  
    
 
 
   
 
 
 
Total Liabilities
  
 
2,807,409
 
 
 
1,728,885
 
    
 
 
   
 
 
 
Commitments and Contingencies (Note 6)
           
Class A common stock: 9,789,446 and 25,875,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively
     106,318,563       270,278,722  
Shareholders’ Deficit
                
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding
                  
Class A ordinary shares, $0.0001 par value; 479,000,000
 s
hares authorized; none issued or outstanding
                  
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 6,468,750 shares issued and outstanding
(1)
     647       647  
Additional paid in capital
                  
Accumulated deficit
     (2,459,901     (400,635
    
 
 
   
 
 
 
Total Shareholders’ Deficit
  
 
(2,459,254
)
 
 
 
(399,988
    
 
 
   
 
 
 
Total Liabilities and Shareholders’ Deficit
  
$
106,666,799
 
 
$
271,607,619
 
    
 
 
   
 
 
 
 
(1)
On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
1

INVESTCORP INDIA ACQUISITION CORP
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
    
Three Months Ended

September 30,
   
Nine Months Ended
September 30,
 
    
2023
   
2022
   
2023
   
2022
 
Formation costs and operating expenses
   $ 461,510     $ 273,246     $ 1,307,228     $ 796,793  
    
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
  
$
(461,510
)
 
$
(273,246
)
 
$
(1,307,228
)
 
 
$
(796,793
Other income:
                                
Interest earned on investments held in Trust Account
     2,503,463       1,204,462       8,614,558       1,466,458  
Change in fair value of warrant liability
     (831,938     1,451,250       (552,038     2,902,500  
    
 
 
   
 
 
   
 
 
   
 
 
 
Other income
     1,671,525       2,655,712       8,062,520       4,368,958  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net income
  
$
1,210,015
 
 
$
2,382,466
 
 
$
6,755,292
 
 
$
3,572,165
 
    
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding of Class A ordinary shares
     18,274,134       25,875,000       23,341,378       13,364,011  
Basic and diluted net income per ordinary share, Class A ordinary shares
   $ 0.05     $  0.07     $ 0.23     $ 0.18  
  
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding of Class B ordinary shares (1)
     6,468,750       6,468,750       6,468,750       6,682,005  
Basic and diluted net income per ordinary share, Class B ordinary shares
  
$
0.05
   
$
 0.07
   
$
0.23
 
 
$
0.18
 
  
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to
843,750
shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2

INVESTCORP INDIA ACQUISITION CORP
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023
(UNAUDITED)
 
    
Class B Ordinary

Shares
    
Additional
Paid-in

Capital
    
Accumulated
Deficit
   
Total
Shareholders’
Deficit
 
    
Shares
    
Amount
 
Balance — December 31, 2022
  
 
6,468,750
 
  
$
647
 
  
$
  
 
  
$
(400,635
 
$
(399,988
Accretion of Class A ordinary shares subject to possible redemption
     —          —                    (2,889,862     (2,889,862
Net income
     —          —          —          2,012,699       2,012,699  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — March 31, 2023
  
 
6,468,750
 
  
$
647
 
  
$
 —  
 
  
$
(1,277,798
 
$
(1,277,151
Accretion of Class A ordinary shares subject to possible redemption
     —          —                    (3,221,233     (3,221,233
Net income
     —          —          —          3,532,578       3,532,578  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — June 30, 2023
  
 
6,468,750
 
  
$
647
 
  
 
—  
 
  
 
(966,453
 
 
(965,806
Accretion of Class A ordinary shares subject to possible redemption
     —          —          —          (2,703,463     (2,703,463
Net Income
     —          —          —          1,210,015       1,210,015  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — September 30, 2023
  
 
6,468,750
 
  
 
647
 
  
 
—  
 
  
 
(2,459,901
 
 
(2,459,254
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022
(UNAUDITED)
 
    
Class B Ordinary
Shares
    
Additional
Paid-in

Capital
   
Accumulated
Deficit
   
Total
Shareholders’
Deficit
 
    
Shares
    
Amount
 
Balance — December 31, 2021
  
 
6,468,750
 
  
$
647
 
  
$
24,353
 
 
$
(3,587
 
$
21,413
 
Net loss
     —          —                                
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — March 31, 2022
  
 
6,468,750
    
$
647
    
$
24,353
 
 
$
(3,587
 
$
21,413
 
Excess cash received over fair value for private placement warrants
     —          —          12,870,000               12,870,000  
Accretion of Class A ordinary shares subject to possible redemption
     —          —          (12,894,353     (3,684,712     (16,579,065
Net Income
     —          —          —         1,189,699       1,189,699  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — June 30, 2022
  
 
6,468,750
 
  
$
647
 
  
$
  
 
 
$
(2,498,600
 
$
(2,497,953
Accretion of Class A ordinary shares subject to possible redemption
     —          —          —         (1,204,462     (1,204,462
Net Income
     —          —          —         2,382,466       2,382,466  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — September 30, 2022
  
 
6,468,750
 
  
$
647
 
  
$
—  
 
 
$
(1,320,596
 
$
(1,319,949
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3

INVESTCORP INDIA ACQUISITION CORP
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
 
    
Nine Months Ended

September 30, 2023
   
Nine Months Ended
September 30, 2022
 
Cashflow from Operating Activities:
                
Net income
   $ 6,755,292     $ 3,572,165  
Adjustments to reconcile net income to net cash used in operating activities:
                
Change in fair value of warrant liability
     552,038       (2,902,500
Interest earned on investments held in Trust Account
     (8,614,558     (1,466,458
Changes in operating assets and liabilities:
                
Other assets
     375,510       (826,074
Accrued expenses
     329,556       78,150  
Due to Sponsor
     (2,989     (302,528
    
 
 
   
 
 
 
Net cash used in operating activities
  
 
(605,151
 
 
(1,847,245
    
 
 
   
 
 
 
Cashflow from Investing Activities:
                
Investment of cash into Trust Account
     172,774,717       (266,512,500
Cash deposited in Trust Account
     (200,000     —    
    
 
 
   
 
 
 
Net cash provided by (used in) investing activities
  
 
172,574,717
   
 
(266,512,500
    
 
 
   
 
 
 
Cashflow from Financing Activities:
                
Payments to Redeeming Shareholders
     (172,774,717     —    
Proceeds from Sale of Units, net of underwriting discounts paid
             253,575,000
 
Proceeds from promissory note – related party
     200,000        
Proceeds from sale of Private Placements Warrants
     —         16,087,500  
Advances from Sponsor
     —         25,000  
Payment of offering costs
     —         (469,891
    
 
 
   
 
 
 
Net cash (used in) provided by financing activities
  
 
(172,574,717
 
 
269,217,609
 
    
 
 
   
 
 
 
Net Change in Cash
  
 
(605,151
 
 
857,864
 
Cash at the beginning of the period
     635,565        
    
 
 
   
 
 
 
Cash at the end of the period
  
$
30,414
 
 
$
857,864
 
    
 
 
   
 
 
 
Non-cash
investing and financing activities:
                
            
 
 
 
Accretion of Class A ordinary shares subject to possible redemption
   $ 8,814,558     $  —    
    
 
 
   
 
 
 
Deferred offering costs paid through Due to Sponsor
   $         $ 325,765  
  
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Investcorp India Acquisition Corp (the “Company”) is a blank check company incorporated in the Cayman Islands on February 19, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On January 11, 2022, the Company changed its name from Investcorp Acquisition Corp. to Investcorp India Acquisition Corp.
As of September 30, 2023, and for the period from February 19, 2021 (inception) through September 30, 2023, the Company had not yet commenced any operations. All activity for the period from February 19, 2021 (inception) through September 30, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s Initial Public Offering was declared effective on May 9, 2022. On May 12, 2022, the Company consummated the Initial Public Offering of 22,500,000 unit (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option in full, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 14,400,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to ICE I Holdings Pte. Ltd. (the “Sponsor”), generating gross proceeds of $14,400,000. In connection with the underwriter’s exercise of their over-allotment option, the Company also consummated the sale of an additional 1,687,500 Private Placement Warrants at $1.00 per Private Placement Warrant generating total proceeds of $1,687,500, which is described in Note 4.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Offering, management has agreed that $10.30 per Unit sold in the Proposed Offering, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule
2a-7
under the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company provides its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.
If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.
 
5


The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.30 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Class A ordinary shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
The Company’s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s
pre-Business
Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to shareholders’ rights of
pre-Business
Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination.
On August 11, 2023 shareholders of the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024.
In connection with the Extension Amendment Proposal, the Sponsor has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. Additionally, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.
At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights (the “Extension Amendment Proposal”). Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.
If the Company is unable to complete a Business Combination within the combination period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a
per-
share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholder’s rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. In the event the Company does not complete a Business Combination within the Combination Period, and in such event, the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Initial Offering price per Unit of $10.00.
 
6


The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.30 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.30 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity, Capital Resources, and Going Concern Consideration
As of September 30, 2023, the Company had $30,414 in cash and a working capital deficit of $427,503.
The Company’s liquidity needs up to September 30, 2023, had been satisfied by funds from the Sponsor to cover certain offering expenses. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company a Working Capital Loans, as defined below (see Note 5). As of September 30, 2023, there were no amounts outstanding under any Working Capital Loans.
Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statement. However, the Company completed its Initial Public Offering, as detailed in Note 3, which generated capital in excess of the funds deposited into a trust account. This excess capital may be used by the Company for general working capital purposes.
In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The Company originally had until August 12, 2023, 15 months from the closing of the IPO, to consummate a Business Combination. As approved by its shareholders, the Company extended the time to complete a Business Combination to August 12, 2024, 23 months from the closing of the IPO). It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by August 12, 202
4, there will be a mandatory liquidation and subsequent dissolution. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that this financial statement is issued. This financial statement does not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Management is currently evaluating the impact of the
COVID-19
pandemic and geopolitical instability, such as the military conflict in Ukraine and the Middle East, and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The Inflation Reduction Act of 2022, enacted in August 2022, imposes a 1% excise tax on the fair market value of stock repurchased by “covered corporations” beginning in 2023, with certain exceptions (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders. Because we are a “blank check” Cayman Islands corporations with no subsidiaries or previous merger or acquisition activity, we are not currently a “covered corporation” for this purpose. The amount of the Excise Tax is generally equal to 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, there are certain other exceptions to the Excise Tax. The U.S. Department of the Treasury has been given authority to issue regulations or other guidance to carry out, and to prevent the avoidance of, the Excise Tax. The Treasury and the IRS recently have issued preliminary guidance regarding the application of this excise tax, but there can be no assurance that this guidance will be finally adopted in its current form. A repurchase that occurs in connection with a business combination with a U.S. target company might be subject to the Excise Tax, depending on the structure of the business combination and other transactions that might be engaged in during the relevant year.
 
7

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Use of Credit Risk
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,414 and $635,565 cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.
Investments Held in Trust Account
As of September 30, 2023, and December 31, 2022, the Company had $106,318,563 and $270,278,722, respectively, held in money market funds, which are invested primarily in U.S. Treasury Securities.
 
8

Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company has completed a nexus study and believes that it is appropriately filing tax returns in which it has nexus.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings per Share”. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 843,750 Class B ordinary shares that are subject to forfeiture if the over- allotment option is not exercised by the underwriter (see Note 8). Diluted net income per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination, they have not been included in the calculation of diluted net income per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:
 
    
For the Three Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $  893,670      $ 316,345      $ 1,905,973      $  476,493  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     18,274,134        6,468,750        25,875,000        6,468,750  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.05      $  0.05      $ 0.07      $  0.07  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
9


    
For the Nine Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $ 5,289,404      $ 1,465,888      $ 2,381,443      $ 1,190,722  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     23,341,378        6,468,750        13,364,011        6,682,005  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.23      $  0.23      $ 0.18      $  0.18  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
 
   
Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
 
   
Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
 
   
Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering
The Company complied with the requirements of the ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consists of legal, accounting, underwriting fees and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $6,037,027, which was charged to shareholders’ equity upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
 
10


The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.
As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:
 
Gross Proceeds
   $ 258,750,000  
Less:
        
Proceeds allocated to Public Warrants
     (2,587,500
Total stock issuance costs
     (5,967,069
Plus:
        
Accretion of carrying value to redemption value
     20,083,291  
    
 
 
 
Class A ordinary shares subject to possible redemption at December 31, 2022
  
$
270,278,722
 
Plus:
        
Accretion of carrying value to redemption value
     8,814,558  
Less:
        
Shares redeemed in August 2023
     (172,774,717
    
 
 
 
Class A ordinary shares subject to possible redemption at September 30, 2023
  
$
 106,318,563
 
    
 
 
 
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using a Modified Binomial Option Pricing model (see Note 9).
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
 
11


Recently Issued Accounting Standards
In August 2020, the FASB issued Accounting Standards Update (“ASU”)
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021, and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company is still evaluating the impact on the Company’s financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 25,875,000 Units at a purchase price of $10.00 per Unit. Each Unit consisted of one Class A ordinary share, $0.0001 par value, and
one-half
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 8).
NOTE 4. PRIVATE PLACEMENT
The Sponsor purchased an aggregate of 16,087,500 Private Placement Warrants at a price of $1.00 per warrant, in a private placement that closed simultaneously with the closing of the Initial Public Offering.
Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On March 12, 2021, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In March 2022, our sponsor surrendered, for no consideration, 718,750 founder shares, resulting in our sponsor holding 6,468,750 founder shares for an aggregate purchase price of $25,000 or approximately $0.039 per share. The Founder Shares include an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so that the Sponsor will collectively own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.
As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 120 days after the Business Combination, the Founder Shares will be released from the
lock-up.
Promissory Note — Related Party
On March 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Proposed Offering pursuant to a promissory note (the “Note”). The Note is
non-interest
bearing and is payable on the earlier of (i) December 31, 2021 (which was amended to September 30, 2022, on January 25, 2022) or (ii) the consummation of the Initial Proposed Offering. As of September 30, 2023, and December 31, 2022, there were no amounts outstanding on the Note and it is no longer available to the Company.
 
12


Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2023, and December 31, 2022, the Company has not drawn on the Working Capital Loans.
Due to Sponsor
The Sponsor has paid expenses on behalf of the Company prior to the Company’s Initial Public Offering. This amount is not interest bearing and due on demand by the Sponsor. As of September 30, 2023, and December 31, 2022, there was $39,435 and $42,424 due to Sponsor, respectively.
Extension Loans — related party
If the Company anticipates that it may not be able to consummate its initial business combination within 15 months, the Company may, but is not obligated to, extend the period of time to consummate a Business Combination by an additional three months on two separate occasions (for a total of up to 21 months to complete a business combination). In order to extend the time available for us to consummate a Business Combination, the Sponsor (or its affiliates or designees), upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $2,587,500 ($0.10 per share), on or prior to the date of the applicable deadline. Any such payments would be funded from the proceeds of a
non-interest-bearing
loan between the Sponsor and the Company (the “Extension Loans”). Such Extension Loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The terms of the warrants would be identical to the terms of the private placement warrants. If the Company completes a Business Combination, the Company would repay such Extension Loans out of the proceeds of the trust account released to the Company. There were no amounts outstanding on the extension loans as of September 30, 2023, and December 31, 2022.
As a result of the shareholders’ vote held on August 11, 2023, the Company has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s IPO (including any shares issued in exchange thereof) that are not redeemed at the Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. For the avoidance of doubt, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.
Promissory Note
On August 9, 2023, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover expenses related to the Contributions (the “2023 Note”). The note is
non-interest
bearing and is payable on the earlier of (i) August 12, 2024, or (ii) the consummation of a Business Combination. Upon receiving notice of the closing of a Business Combination, the Sponsor shall convert the unpaid principal balance of the 2023 Note into a number of
non-transferable,
non-redeemable
ordinary shares of the Company equal to (x) the principal amount of the 2023 Note being converted, divided by (y) the conversion price of $10.00, rounded up to the nearest whole number of shares. As of September 30, 2023, the outstanding principal balance was $200,000
. Subsequently, on October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note of $100,000
each month to fund month extension requirements.
Administrative Services Agreement
Commencing on the date of the Initial Public Offering and until completion of the Company’s initial business combination or liquidation, the Company will make a payment of a monthly fee of $10,000 to the Sponsor for office space, utilities and secretarial and administrative services provided to the Company. As of September 30, 2023 and December 31, 2022, there was $90,000 and $60,000 recorded in accrued expenses, respectively.
 
13

NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans and Extension Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriter a
45-day
option to purchase up to 3,375,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The over-allotment option was exercised simultaneously with the Initial Public Offering.
NOTE 7. WARRANT LIABILITY
The Company accounts for the 29,025,000 warrants issued in connection with the Initial Public Offering (the 16,087,500 Private Warrants and the 12,937,500 Public Warrants) in accordance with the guidance contained in ASC 480 and ASC
815-40,
Derivatives and Hedging. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to
re-measurement
at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the ordinary share warrants. At that time, the portion of the warrant liability related to the ordinary share warrants will be reclassified to additional
paid-in
capital.
Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the consummation of a Business Combination. The Public Warrants will expire
five years
from the consummation of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.
The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $
18.00
. Once the warrants become exercisable, the Company may redeem the Warrants for redemption:
 
   
in whole and not in part;
 
   
at a price of $
0.01
per Public Warrant;
 
   
upon not less than
30
days’ prior written notice of redemption to each warrant holder and
 
14

   
if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $
18.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
20
trading days within a
30
-trading
day period ending three business days before the Company sends the notice of redemption to the warrant holders.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30
-day
redemption period. If and when the warrants become redeemable by us, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $
10.00
. Once the Warrants become exercisable, the Company may redeem the Warrants for redemption:
 
   
in whole and not in part;
 
   
at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Shareholders’ Warrants”;
 
   
if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the
30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
   
if the closing price of our Class A ordinary shares for any
20
trading days within a
30
-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $
18.00
per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Shareholders’ Warrants — Anti-Dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of ordinary shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.
The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such
 
15

initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.
The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Proposed Offering, except that the Private Placement Warrants will and the ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
NOTE 8. SHAREHOLDERS’ DEFICIT
Preference Shares — The Company is authorized to issue 1,000,000 preference shares of $0.0001 par value. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class A Ordinary Shares — The Company is authorized to issue up to 479,000,000 Class A ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023, and December 31, 2022, there were 9,789,446 and 25,875,000 Class A ordinary shares issued and outstanding, respectively.
Class B Ordinary Shares — The Company is authorized to issue up to 20,000,000 Class B ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 6,468,750 Class B ordinary shares issued and outstanding, respectively.
On March 22, 2022, the Sponsor surrendered, for no consideration, 718,750 Class B ordinary shares, resulting in our sponsor holding 6,468,750 founder shares issued and outstanding, of which an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.
The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the completion of our Business Combination on a
one-for-one
basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional Class A ordinary shares, or equity linked securities, are issued or deemed issued in connection with the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all ordinary shares outstanding as of the Initial Public Offering plus all Class A ordinary shares and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.
The Company may issue additional ordinary shares or preference shares to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.
NOTE 9. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
  Level 1:  
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
16

 
Level 2:  
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
  Level 3:  
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
As of September 30, 2023, and December 31, 2022, investments held in the Trust Account were comprised of $106,318,563 and $270,278,722 in money market funds, which are invested primarily in U.S. Treasury Securities, respectively. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
    
Level
    
September 30, 2023
    
December 31, 2022
 
Assets:
                          
Investments held in Trust Account
     1      $ 106,318,563      $ 270,278,722  
Liabilities:
                          
Public Warrants
     1      $ 905,625      $ 675,338  
Private Warrants
     3      $ 1,126,125      $ 804,375  
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. During the period there were no transfers to/from Levels 1 and 3.
The Company established the initial fair value of the warrants on May 12, 2022, the date of the consummation of the Company’s IPO. The Company used a Binomial Option Pricing model to value the warrants. The Company allocated the proceeds received from (i) the sale of the Units (which is inclusive of one share of Class A ordinary shares and
one-half
of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), Class A ordinary shares (permanent equity) and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date.
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
September 30,
2023
   
December 31,
2022
 
    
Private
Warrants
   
Private
Warrants
 
Stock Price
   $  10.81     $  10.34  
Exercise Price
   $  11.50     $  11.50  
Risk-free rate of interest
     4.60 %     3.99 %
Volatility
     0.50 %     0.50 %
Term
     1.5 years       2.8 years  
The Private Placement Warrants were initially and subsequently valued using a Binomial Option Pricing model, which is considered to be a Level 3 fair value measurement. The fair value of Public Warrants issued in connection with the Initial Public Offering were initially measured using a Binomial Option Pricing model and at September 30, 2023 and December 31, 2022 are measured based on the listed market price of such warrants, a Level 1 measurement.
 
17

 
The Binomial Option Pricing model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility as of the IPO date was derived from observable warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing.
The following table presents a summary of the changes in the fair value of the Private Placement Warrants, Level 3 liabilities, measured on a recurring basis.

 
 
  
Private Warrants
 
Fair value as of January 1, 2022
  
$
  
 
Initial measurement on May 12, 2022 warrants issued
  
 
3,217,500
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of June 30, 2022
  
$
2,413,125
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of September 30, 2022
  
$
1,608,750
 
 
  
 
 
 
 
Fair value as of January 1, 2023
  
$
804,375
 
Changes in fair value (1)
  
 
321,750
 
 
  
 
 
 
Fair Value as of March 3
1
, 2023
  
$
1,126,125
 
 
  
 
 
 
Change in fair value (1)
  
 
(482,625
 
  
 
 
 
Fair Value as of June 30, 2023
  
$
643,500
 
 
  
 
 
 
Change in fair value (1)
  
 
482,625
 
 
  
 
 
 
Fair value as of September 30, 2023
  
$
1,126,125
 
 
  
 
 
 
 
(1)
Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date
that
the unaudited condensed financial statements were issued. Based upon this review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
On October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note (“2023 Note”) of $100,000
each month to fund month extension requirements.
On October 11, 2023 and November 13, 2023 the Company deposited $100,000
each month into the Trust Account in order to effect the third and fourth subsequent one month extensions of the Revised Extension Deadline, which extended the deadline to consummate the Business Combination to December 12, 2023. 
 
18
 


Table of Contents
ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Investcorp India Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to ICE I Holdings Pte. Ltd. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Overview

We are a blank check company incorporated on February 19, 2021, as a Cayman Islands exempted company and formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report as our “initial business combination”. While we may pursue an initial business combination target in any industry, we intend to focus our search on companies within the Indian market. We intend to effectuate our initial business combination using remaining cash in the trust account from the proceeds of the offering and the private placement of the Private Placement Warrants (as defined below), the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.

Recent Developments

On August 11, 2023 shareholders of the Company held an Extraordinary General Meeting. At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024.

In connection with the Extension Amendment Proposal, the Sponsor has agreed to contribute into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. Additionally, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.

At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights. Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.

On October 11, 2023 and November 13, 2023 the Company deposited $100,000 each month into the Trust Account in order to effect the third and fourth subsequent one month extensions of the Revised Extension Deadline, which extended the deadline to consummate the Business Combination to December 12, 2023.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities for the period from February 19, 2021 (inception) through September 30, 2023, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and after our Initial Public Offering, identifying target companies for a business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of interest income on cash and cash equivalents held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as due diligence expenses.

 

19


Table of Contents

For the three months ended September 30, 2023, we had net income of $1,210,015, which consists of operating costs of $461,510, loss due to change in fair value of warrants of $831,938, offset by interest earned from investments held in the Trust Account of $2,503,463. For the three months ended September 30, 2022, we had a net income of $2,382,466, which consists of operating costs of $273,246, offset by interest earned from investments held in the Trust Account of $1,204,462 and change in fair value of warrants of $1,451,250.

For the nine months ended September 30, 2023, we had net income of $6,755,292, which consists of operating costs of $1,307,228, loss due to change in fair value of warrants of $552,038, offset by interest earned from investments held in the Trust Account of $8,614,558. For the nine months ended September 30, 2022, we had a net income of $3,572,165, which consists of operating costs of $796,793, offset by interest earned from investments held in the Trust Account of $1,466,458 and change in fair value of warrants of $2,902,500.

Liquidity, Capital Resources, and Going Concern Consideration

As of September 30, 2023, the Company had $30,414 in cash and a working capital deficit of $427,503.

On May 12, 2022, we consummated the Initial Public Offering of 22,500,000 Class A Public Shares at $10.00 per Public Share, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 14,400,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to ICE I Holdings Pte, Ltd. (the “Sponsor”), generating gross proceeds of $14,400,000. In connection with the underwriter’s exercise of their over-allotment option, the Company also consummated the sale of an additional 1,687,500 Private Placement Warrants at $1.00 per Private Placement Warrant generating total proceeds of $1,687,500.

For the nine months ended September 30, 2023, cash used in operating activities was $605,151. Net income of $6,755,292 was affected by a gain on the change in the fair value of the warrant liability of $552,038 and interest income of $8,614,558. Changes in operating assets and liabilities used $702,077 of cash for operating activities.

For the nine months ended September 30, 2022, cash used in operating activities was $1,847,245. Net income of $3,572,165 was affected by a gain on the change in the fair value of the warrant liability of $2,902,500 and interest income of $1,466,458. Changes in operating assets and liabilities used $1,050,452 of cash for operating activities.

As of September 30, 2023, we had investments held in the Trust Account of $106,318,563. Interest income on the balance in the Trust Account may be used by us to pay taxes. We intend to use substantially all of the funds held the Trust Account and the proceeds from the sale of the forward purchase shares to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2023, we had cash of $30,414 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties, or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

In connection with the Company’s assessment of going concern considerations in accordance with ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August 12, 2024, 23 months from the closing of the IPO, to consummate a Business Combination unless an extension is granted. It is uncertain that the Company will be able to consummate an initial Business Combination within this time. If an initial Business Combination is not consummated within this time, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should an initial Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 12, 2024.

 

20


Table of Contents

Off-Balance Sheet Arrangements

As of September 30, 2023, and December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or other long-term liabilities, other than described below:

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants) will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

Promissory Note—Related Party

On March 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note is non-interest bearing and is payable on the earlier of (i) December 31, 2021 (which was amended to September 30, 2022, on January 25, 2022), or (ii) the consummation of the Initial Public Offering. As of September 30, 2023 and December 31, 2022, there were no amounts outstanding on the Note and it is no longer available to the Company.

Promissory Note

On August 9, 2023, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover expenses related to the Contributions (the “2023 Note”). The note is non-interest bearing and is payable on the earlier of (i) August 12, 2024, or (ii) the consummation of a Business Combination. Upon receiving notice of the closing of a Business Combination, the Sponsor shall convert the unpaid principal balance of the 2023 Note into a number of non-transferable, non-redeemable ordinary shares of the Company equal to (x) the principal amount of the 2023 Note being converted, divided by (y) the conversion price of $10.00, rounded up to the nearest whole number of shares. As of September 30, 2023, the outstanding principal balance was $200,000. Subsequently, on October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note of $100,000 to fund month extension requirements.

Underwriter’s Agreement

The Company granted the underwriter a 45-day option to purchase up to 3,375,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. Concurrently with the consummation of the IPO, the underwriters exercised the over- allotment option to purchase an additional 3,375,000 units.

 

21


Table of Contents

Critical Accounting Estimates

This management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company has identified the following as its critical accounting estimates:

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

On August 11, 2023 shareholders of the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024. At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights (the “Extension Amendment Proposal”). Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.

Warrants

The Company accounts for the Warrants as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the Warrants and the applicable authoritative guidance in ASC 480, and ASC 815. The assessment considers whether they are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to the Company’s own ordinary shares and whether the holders of the Warrants could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and as of each subsequent quarterly period end date while the Warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, such warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, such warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified warrants are recognized as a non-cash gain or loss on the statements of operations.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

 

22


Table of Contents

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

23


Table of Contents
ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our current chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2023, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Based on this evaluation, our chief executive officer and chief financial officer have concluded that, during the period covered by this report, our disclosure controls and procedures were not effective as of September 30, 2023, because of an identified material weakness in our internal control over financial reporting. The material weakness identified relates to an ineffective review control to prevent or detect a material misstatement, which resulted in a material adjustment to accrued expenses in relation to the filing of its Form 8-K on May 26, 2022.

The Company, with the oversight of its Audit Committee, is actively undertaking remediation efforts to address the material weakness identified above and is developing measures and controls to prevent a re-occurrence of such a deficiency in the future.

The Company is committed to maintaining an effective internal control environment, and although it has made progress in this area, additional steps need to be taken, as indicated above, and sufficient time needs to elapse before management can conclude that the newly implemented controls are operating effectively and that the material weakness has been adequately remediated.

Management’s Report on Internal Controls Over Financial Reporting

This Quarterly Report on Form 10-Q does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

24


Table of Contents

PART II - OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

None.

 

ITEM 1A.

RISK FACTORS

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in (i) our final prospectus for our Initial Public Offering filed with the SEC on May 10, 2022, and (ii) our annual report on Form 10-K filed with the SEC on April 17, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in (i) our final prospectus for our Initial Public Offering filed with the SEC on May 10, 2022 or (ii) our annual report on Form 10-K filed with the SEC on April 17, 2023, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities

In March 2021, our Sponsor purchased 7,187,500 Class B ordinary shares, par value $0.0001, for an aggregate price of $25,000. In March 2022, our sponsor surrendered, for no consideration, 718,750 founder shares, resulting in our sponsor holding 6,468,750 founder shares for an aggregate purchase price of $25,000 or approximately $0.039 per share.

On May 12, 2022, we consummated the Initial Public Offering of 22,500,000 unit, at $10.00 per Unit, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000.

Simultaneously with the closing of the Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreements, the Company completed the private sale of 16,087,500 warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $16,087,500. The Private Placement Warrants are identical to the Warrants included as part of the Units sold in the IPO.

No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Use of Proceeds

In connection with the Initial Public Offering, we incurred offering costs of $6,037,027, consisting of $5,175,000 of underwriting fees, and $862,027 of other offering costs. After deducting the underwriting discounts and commissions and the Initial Public Offering expenses, $266,512,500 of the net proceeds from our Initial Public Offering and from the Private Placement of the Private Placement Warrants was placed in the Trust Account. The net proceeds of the Initial Public Offering and certain proceeds from the sale of the Private Placement Warrants are held in the Trust Account and invested as described in the initial public offering prospectus.

There has been no material change in the planned use of the proceeds from the Initial Public Offering and Private Placement.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

 

25


Table of Contents
ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

 

ITEM 5.

OTHER INFORMATION

None.

 

26


Table of Contents
ITEM 6.

EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit
No.
   Description
  31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS    Inline XBRL Instance Document
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH    Inline XBRL Taxonomy Extension Schema Document
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*

Filed herewith.

**

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

27


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

INVESTCORP INDIA ACQUISITION CORP

  
/s/ Nikhil Kalghatgi    November 30, 2023

Name: Nikhil Kalghatgi

  

Title: Principal Executive Officer

  

 

28